Literature DB >> 8567594

Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes.

S I Pfeiffer1, J Norton, L Nelson, S Shott.   

Abstract

Pauling's orthomolecular hypothesis appeared in 1968, stating that some forms of mental illness and disease are related to biochemical errors in the body. Vitamin therapy is believed to be a means of compensating for such errors. There have been few empirical studies on vitamin therapy in individuals with autism. This article presents a critical analysis of the 12 published studies located through an extensive computerized search. Studies were systematically evaluated to provide an objective assessment of empirical evidence supporting the efficacy of vitamin treatment. The majority of studies report a favorable response to vitamin treatment. However, interpretation of these positive findings needs to be tempered because of methodological shortcomings inherent in many of the studies. For example, a number of studies employed imprecise outcome measures, were based on small samples and possible repeat use of the same subjects in more than one study, did not adjust for regression effects in measuring improvement, and omitted collecting long-term follow-up data. Recommendations are offered to assist researchers in designing future investigations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8567594     DOI: 10.1007/bf02178295

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  23 in total

1.  Electrophysiological effects of fenfluramine or combined vitamin B6 and magnesium on children with autistic behaviour.

Authors:  J Martineau; C Barthelemy; S Roux; B Garreau; G Lelord
Journal:  Dev Med Child Neurol       Date:  1989-12       Impact factor: 5.449

2.  Brief report: an open middle-term study of combined vitamin B6-magnesium in a subgroup of autistic children selected on their sensitivity to this treatment.

Authors:  J Martineau; C Barthelemy; C Cheliakine; G Lelord
Journal:  J Autism Dev Disord       Date:  1988-09

3.  [Experiences with pyrithioxin in brain-damaged children with autistic syndrome].

Authors:  E Bönisch
Journal:  Prax Kinderpsychol Kinderpsychiatr       Date:  1968 Nov-Dec

4.  Experiences with response averaging in autistic children.

Authors:  J G Small; M K DeMyer; J K Kendall
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1969-01

5.  [Biological and clinical effects of oral magnesium and associated magnesium-vitamin B6 administration on certain disorders observed in infantile autism (author's transl)].

Authors:  C Barthelemy; B Garreau; I Leddet; D Sauvage; J Domenech; J P Muh; G Lelord
Journal:  Therapie       Date:  1980 Sep-Oct       Impact factor: 2.070

6.  [Disturbances in dopamine metabolism in autistic children: results of clinical tests and urinary dosages of homovanilic acid (HVA)].

Authors:  B Garreau; C Barthelemy; J Domenech; D Sauvage; J P Muh; G Lelord; E Callaway
Journal:  Acta Psychiatr Belg       Date:  1980 May-Jun

7.  The effect of high doses of vitamin B6 on autistic children: a double-blind crossover study.

Authors:  B Rimland; E Callaway; P Dreyfus
Journal:  Am J Psychiatry       Date:  1978-04       Impact factor: 18.112

8.  [Modifications in urinary homovanillic acid after ingestion of vitamin B6; functional study in autistic children (author's transl)].

Authors:  G Lelord; E Callaway; J P Muh; J C Arlot; D Sauvage; B Garreau; J Domenech
Journal:  Rev Neurol (Paris)       Date:  1978-12       Impact factor: 2.607

9.  A neurological model for childhood autism.

Authors:  A R Damasio; R G Maurer
Journal:  Arch Neurol       Date:  1978-12

10.  Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism.

Authors:  J Martineau; C Barthelemy; B Garreau; G Lelord
Journal:  Biol Psychiatry       Date:  1985-05       Impact factor: 13.382

View more
  9 in total

1.  Hemoglobin and the brain: a piece of the autism puzzle?

Authors:  N Simon
Journal:  J Autism Dev Disord       Date:  1998-12

Review 2.  Prognosis in autism: do specialist treatments affect long-term outcome?

Authors:  P Howlin
Journal:  Eur Child Adolesc Psychiatry       Date:  1997-06       Impact factor: 4.785

Review 3.  Pharmacotherapy of pervasive developmental disorders in children and adolescents.

Authors:  Gabriele Masi
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders.

Authors:  Richard P Malone; Silvia S Gratz; Mary Anne Delaney; Susan B Hyman
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study.

Authors:  R L Findling; K Maxwell; L Scotese-Wojtila; J Huang; T Yamashita; M Wiznitzer
Journal:  J Autism Dev Disord       Date:  1997-08

Review 6.  Combined vitamin B6-magnesium treatment in autism spectrum disorder.

Authors:  C Nye; A Brice
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

Review 7.  Complementary and alternative medicine treatments for children with autism spectrum disorders.

Authors:  Susan E Levy; Susan L Hyman
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-10

8.  The role of vitamins and minerals in psychiatry.

Authors:  Stacey Cornish; Lewis Mehl-Madrona
Journal:  Integr Med Insights       Date:  2008-09-24

9.  A review of complementary and alternative treatments for autism spectrum disorders.

Authors:  Nicholas Lofthouse; Robert Hendren; Elizabeth Hurt; L Eugene Arnold; Eric Butter
Journal:  Autism Res Treat       Date:  2012-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.